Abstract
The term monoclonal gammopathy of undetermined significance (MGUS) denotes the presence of a monoclonal protein (M protein) in persons without evidence of multiple myeloma (MM), Waldenström's macroglobulinemia (WM), AL amyloidosis (AL), or other related diseases. MGUS is characterized by a serum M-protein concentration of less than 3.0 g/dL; less than 10 % clonal plasma cells in the bone marrow; and the absence of end-organ damage (CRAB-hypercalcemia, renal insufficiency, anemia, and bone lesions) related to the plasma cell proliferative disorder [1-4].
Original language | English (US) |
---|---|
Title of host publication | Neoplastic Diseases of the Blood |
Publisher | Springer New York |
Pages | 751-785 |
Number of pages | 35 |
ISBN (Electronic) | 9781461437642 |
ISBN (Print) | 1461437636, 9781461437635 |
DOIs | |
State | Published - Nov 1 2013 |
Keywords
- Long-term outcome of MGUS
- MGUS association with other diseases
- MGUS prevalence
- Risk factors for progression of MGUS
- Variants of MGUS
ASJC Scopus subject areas
- Medicine(all)